Office of Health Economics, profile picture

Office of Health Economics

Sort by
Annual lecture
Devlin ispor 2020 issues panel 20.05.20
Towse 2020 antimicrobials melbourne final
Towse cgd price transparency seminar
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
% GDP spending in UK, G5 countries and OECD upper middle income countries. Why it is important to have adequate % spending.
The role of real world data and evidence in building a sustainable & efficient healthcare system
ISPOR Education Symposium- Go where the money is
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Lessons from NHS Maternity Services
Novel approaches for valuing health at the end of life
HTA and payment mechanisms for new drugs to tackle AMR
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in Sweden and the UK: The Case of Risperidone
Pay for Performance for Specialised Care in England
Real option value drugs: is it really an option?